On Invalid Date, Wave Life Sciences (NASDAQ: WVE) reported Q1 2023 earnings per share (EPS) of -$0.27, up 56.45% year over year. Total Wave Life Sciences earnings for the quarter were -$27.41 million. In the same quarter last year, Wave Life Sciences's earnings per share (EPS) was -$0.62.
As of Q2 2023, Wave Life Sciences's earnings has grown year over year. Wave Life Sciences's earnings in the past year totalled -$151.41 million.
What is WVE's earnings date?
Wave Life Sciences's earnings date is Invalid Date. Add WVE to your watchlist to be reminded of WVE's next earnings announcement.
What was WVE's revenue last quarter?
On Invalid Date, Wave Life Sciences (NASDAQ: WVE) reported Q1 2023 revenue of $12.93 million up 638.8% year over year. In the same quarter last year, Wave Life Sciences's revenue was $1.75 million.
What was WVE's revenue growth in the past year?
As of Q2 2023, Wave Life Sciences's revenue has grown -65.29% year over year. This is 136.61 percentage points lower than the US Biotechnology industry revenue growth rate of 71.33%. Wave Life Sciences's revenue in the past year totalled $14.83 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.